What is MA's health score?

Mastercard Inc (MA) has a TradeApes health score of 58 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MA's estimated fair value?

Based on our 5-year discounted cash flow model, Mastercard Inc's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is MA undervalued or overvalued?

Our model currently rates MA as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MA... Refresh in a moment for the full analysis.

Mastercard Inc (MA)

Technology Overvalued low mixed

$491.08

Updated: 2026-06-07

TradeApes Score

Financial Strength

80 Strong

Operating Trend

60 Healthy

Relative Value

30 Weak

Capital Allocation

55 Mixed

Risk

70 Healthy

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Above historical median — trading above its own valuation average

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.